$2 million commitment to study commonalities of neurodegenerative diseases

Together, leading funders of research in the US, Canada and the UK are advancing a global funding initiative aimed at better understanding the similarities and differences between progressive brain-deteriorating diseases, such as Alzheimer’s and Parkinson’s, with an expanded partnership and increased funding.